Show
Sort by
-
Early seizures in intracerebral haemorrhage: incidence, associated factors and outcome
-
Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome
-
Influence of deposition and spray pattern of nasal powders on insulin bioavailability
-
Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class
-
In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies
-
Synthesis and preliminary in vivo evaluation of [18F] labelled derivatives of Org 13063 as potential PET radioligands for the 5-HT1A receptor
-
New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents
-
Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings
-
Synthesis and in vivo evaluation in mice and rabbits of [123I]-3-(4-iodobenzyl)-8-methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one as possible agent for imaging of the dopamine D4-receptor
-
Decreased 5-HT2a receptor binding in patients with anorexia nervosa
-
Synthesis and radiolabelling of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D-3 antagonist for SPECT studies
-
Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide
-
Synthesis and in vivo evaluation of [123I]-pyrimidine-Org 13063 as potential SPECT radioligand for the 5-HT1A receptor
-
Regional binding index of the radiolabeled selective 5-ht2a antagonist 123I-5-1-r91150 in the normal canine brain imaged with single photon emission computed tomography
-
Synthesis and radiolabelling of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D-3 antagonist for SPECT studies
-
Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography
-
Synthesis of [C-11] N-(2-chloro-5-thiomethylphenyl)-N '-(3-methoxyphenyl)-N '-methylguanidine ([C-11]GMOM): a candidate PET tracer for imaging the PCP site of the NMDA ion channel.
-
Synthesis and in vitro evaluation of N,N '-diphenyl and N-naphthyl-N '-phenylguanidines as N-methyl-D-aspartate receptor ion-channel ligands.
-
Biodistribution and displacement studies of the selective 5-HT2A receptor antagonist I-123-5-I-R91150 in the normal dog.
-
Synthesis and in vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential sigma receptor ligand for SPECT studies
-
An infected hip prosthesis in a dog diagnosed with a Tc-99m-ciprofloxacin (infecton) scan.
-
Decreased frontal serotonin 5-HT2a receptor binding index in deliberate self-harm patients.
-
Biodistribution and dosimetry of 99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection.
-
Non-invasive methods for absolute cerebral blood flow measurement using 99m-Tc-ECD: A correlation study
-
In vivo evaluation of serotonin-2A receptors in normal canine brain: a SPECT study with a selective 5-HT2a receptor ligand labelled with 123I
-
Biodistribution and dosimetry of Tc-99m-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies
-
Non-invasive methods for absolute cerebral blood flow measurement using Tc-99m-ECD: a study in healthy volunteers
-
Title: Synthesis, biodistribution and blocking studies in mice of a new 123I-labeled dopamine D3 antagonist Dierckx RA, Slegers G
-
Le système serotoninergique dans le comportement suicidaire
-
Synthesis and Preliminary in vivo Evaluation of 4-[123I]iodo-N-{2-[4-(6-trifluoromethylpyridin- 2-yl)-piperazin-1-yl]ethyl}benzamide, a potential SPECT radioligand for the 5- HT1a receptor.
-
Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging?
-
Automated stereotactic standardization of brain SPECT receptor data using single-photon transmission images
-
Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.
-
Biodistribution and dosimetry of [I-123]iodo-PK 11195: a potential agent for SPET imaging of the peripheral benzodiazepine receptor
-
Synthesis and in vitro stability of 123I-labelled annexin V: a potential agent for SPECT imaging of apoptotic cells.
-
Pharmacological evaluation of [C-11]conepezil as tracer for visualization of acetylcholinesterase by PET.
-
Biodistribution and dosimetry of (iodine-123)-iodomethyl-N,N-diethyltamoxifen, an (anti)oestrogen receptor radioligand.
-
Effect of aromatic short-chain analogues of ceramide on axonal growth in hippocampal neurons.
-
In vivo evaluation in mice and metabolism in blood of human volunteers of [I-123]iodo-PK11195: a possible single-photon emission tomography tracer for visualization of inflammation.
-
High-performance liquid chromatography of (11C(1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide in mice plasma and tissue and in human plasma.
-
High-performance liquid chromatographic determination of [11C]1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide in mouse plasma and tissue and in human plasma.
-
Biodistribution and dehalogenation studies of two radiohalogenated kynurenic acid derivatives, potent antagonists of the N-methyl-D-aspartate receptor
-
Radiolabelling optimisation of 7-bromo-5-[I-123]-iodo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid: A potential tracer for NMDA SPECT studies.
-
Synthesis and in vivo evaluation of 7-chloro-5-[I-123]iodo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid.
-
Synthesis of 7-chloro-5-123I-iodokynurenic acid:a possible tracer for in vivo imaging of N-methyl-D-aspartate receptors
-
Synthesis of [Br-77] 5,7-dibromo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid, a possible SPECT tracer for NMDA receptor studies.
-
SYNTHESIS OF 7-BROMO-5-IODO-4-OXO-1,4-DIHYDROQUINOLINE-2-CARBOXYLIC ACID.
-
Synthesis of (J^BT)5, 7-dibromo-4-oxo-l,4-dihydroquinoline-2-carboxylic acid for PET studies of N-methyl-D-aspartate receptors